NYSE:DLB • US25659T1079
ChartMill assigns a Buy % Consensus number of 80% to DLB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-01-30 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-01-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-01-22 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-11-19 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-11-19 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-09-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-09-05 | Baird | Initiate | Neutral |
| 2025-08-15 | Tigress Financial | Maintains | Buy -> Buy |
| 2025-08-01 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-06-13 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-05-15 | Tigress Financial | Maintains | Buy -> Buy |
| 2025-05-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-02 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-02-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-30 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-01-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-23 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-11-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-20 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-06-07 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-06-03 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2024-05-03 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-04-29 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-01-31 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-12-11 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-11-17 | Rosenblatt | Reiterate | Buy -> Buy |
11 analysts have analysed DLB and the average price target is 89.58 USD. This implies a price increase of 40.01% is expected in the next year compared to the current price of 63.98.
The consensus rating for DOLBY LABORATORIES INC-CL A (DLB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.